Bortezomib antagonizes microtubule-interfering drug-induced apoptosis by inhibiting G2/M transition and MCL-1 degradation

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: In: Cell death & disease, 4.2013, e925

Keyword: Krebs
Onkologie

Event: Veröffentlichung

(where): Frankfurt am Main

(who): Univ.-Bibliothek Frankfurt am Main

(when): 2013

Creator: Rapino, Francesca
Naumann, Ivonne
Fulda, Simone

URN: urn:nbn:de:hebis:30:3-355495

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:30 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Rapino, Francesca
Naumann, Ivonne
Fulda, Simone
Univ.-Bibliothek Frankfurt am Main

Time of origin

2013

Other Objects (12)

Homoharringtonine interacts synergistically with bortezomib in NHL cells through MCL-1 and NOXA-dependent mechanisms

Abschnitt

MCL.

Small interfering RNA targeting mcl-1 enhances proteasome inhibitor-induced apoptosis in various solid malignant tumors

Bortezomib

Abschnitt

MCXLI. - MCL.

LncRNA H19 overexpression induces bortezomib resistance in multiple myeloma by targeting MCL-1 via miR-29b-3p

Kapitel

Casus MCL - MCLV

Arctiin-reinforced antioxidant microcarrier antagonizes osteoarthritis progression

CXCL14 antagonizes the CXCL12-CXCR4 signaling axis

Interfering with sleep apnea

Drug-induced uveitis

The MDM2 oncoprotein antagonizes Poly(ADP-ribosyl)ation

Homoharringtonine interacts synergistically with bortezomib in NHL cells through MCL-1 and NOXA-dependent mechanisms

Abschnitt

MCL.

Small interfering RNA targeting mcl-1 enhances proteasome inhibitor-induced apoptosis in various solid malignant tumors

Bortezomib

Abschnitt

MCXLI. - MCL.

LncRNA H19 overexpression induces bortezomib resistance in multiple myeloma by targeting MCL-1 via miR-29b-3p

Kapitel

Casus MCL - MCLV

Arctiin-reinforced antioxidant microcarrier antagonizes osteoarthritis progression

CXCL14 antagonizes the CXCL12-CXCR4 signaling axis

Interfering with sleep apnea

Drug-induced uveitis

The MDM2 oncoprotein antagonizes Poly(ADP-ribosyl)ation

Homoharringtonine interacts synergistically with bortezomib in NHL cells through MCL-1 and NOXA-dependent mechanisms

Abschnitt

MCL.

Small interfering RNA targeting mcl-1 enhances proteasome inhibitor-induced apoptosis in various solid malignant tumors

Bortezomib

Abschnitt

MCXLI. - MCL.

LncRNA H19 overexpression induces bortezomib resistance in multiple myeloma by targeting MCL-1 via miR-29b-3p

Kapitel

Casus MCL - MCLV

Arctiin-reinforced antioxidant microcarrier antagonizes osteoarthritis progression

CXCL14 antagonizes the CXCL12-CXCR4 signaling axis

Interfering with sleep apnea

Drug-induced uveitis

The MDM2 oncoprotein antagonizes Poly(ADP-ribosyl)ation

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Bortezomib antagonizes microtubule-interfering drug-induced apoptosis by inhibiting G2/M transition and MCL-1 degradation

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Time of origin

Other Objects (12)

Homoharringtonine interacts synergistically with bortezomib in NHL cells through MCL-1 and NOXA-dependent mechanisms

MCL.

Small interfering RNA targeting mcl-1 enhances proteasome inhibitor-induced apoptosis in various solid malignant tumors

Bortezomib

MCXLI. - MCL.

LncRNA H19 overexpression induces bortezomib resistance in multiple myeloma by targeting MCL-1 via miR-29b-3p

Casus MCL - MCLV

Arctiin-reinforced antioxidant microcarrier antagonizes osteoarthritis progression

CXCL14 antagonizes the CXCL12-CXCR4 signaling axis

Interfering with sleep apnea

Drug-induced uveitis

The MDM2 oncoprotein antagonizes Poly(ADP-ribosyl)ation

Homoharringtonine interacts synergistically with bortezomib in NHL cells through MCL-1 and NOXA-dependent mechanisms

MCL.

Small interfering RNA targeting mcl-1 enhances proteasome inhibitor-induced apoptosis in various solid malignant tumors

Bortezomib

MCXLI. - MCL.

LncRNA H19 overexpression induces bortezomib resistance in multiple myeloma by targeting MCL-1 via miR-29b-3p

Casus MCL - MCLV

Arctiin-reinforced antioxidant microcarrier antagonizes osteoarthritis progression

CXCL14 antagonizes the CXCL12-CXCR4 signaling axis

Interfering with sleep apnea

Drug-induced uveitis

The MDM2 oncoprotein antagonizes Poly(ADP-ribosyl)ation

Homoharringtonine interacts synergistically with bortezomib in NHL cells through MCL-1 and NOXA-dependent mechanisms

MCL.

Small interfering RNA targeting mcl-1 enhances proteasome inhibitor-induced apoptosis in various solid malignant tumors

Bortezomib

MCXLI. - MCL.

LncRNA H19 overexpression induces bortezomib resistance in multiple myeloma by targeting MCL-1 via miR-29b-3p

Casus MCL - MCLV

Arctiin-reinforced antioxidant microcarrier antagonizes osteoarthritis progression

CXCL14 antagonizes the CXCL12-CXCR4 signaling axis

Interfering with sleep apnea

Drug-induced uveitis

The MDM2 oncoprotein antagonizes Poly(ADP-ribosyl)ation

Related objects

Reset password